Malaria chemoprophylaxis provision in the UK: a call to evaluate the cost-effectiveness and equity implications of universal provision
This position paper advocates for the re-evaluation of the cost-effectiveness and equity of National Health Service-subsidized malaria chemoprophylaxis, considering changes in UK malaria epidemiology, travel patterns, updated travel medicine guidance, novel Plasmodium falciparum treatment pathways and growing awareness and action to tackle sources of health inequities.
Authors
- Peter L. Chiodini (ORCID: https://orcid.org/0000-0003-0317-7090)
- Kirsten A L Morris (ORCID: https://orcid.org/0009-0009-8111-9137)
- Anna M. Checkley
- Hugo C. Turner (ORCID: https://orcid.org/0000-0002-8428-3874)
- David A. Ross (ORCID: https://orcid.org/0000-0001-7426-9561)
Institutions
- University of London (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Hospital for Tropical Diseases (GB)
- Medical Defence Union (GB)
- Ministry of Defence (SI)
- University College London (GB)
- Imperial College London (GB)
- Royal College of Physicians and Surgeons of Glasgow (GB)
Publication Details
- Journal
- Journal of Travel Medicine
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1093/jtm/taaf017
- Primary Topic
- Travel-related health issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00